Strategic Launch Report
and Evaluate Forecast
Predict Payer Uptake of New Drugs With Precision
MMIT Strategic Launch Report provides drug manufacturers with a realistic view of payers’ coverage adoption rates and utilization management within the first year post-launch.The report is paired with consensus forecast data from our partner, Evaluate, for currently approved and pipeline agents within the target indication, to help you identify competitors and challenges and proactively plan your near- and long-term strategies.
Learn More
Predict
Predict one-year uptake of a pipeline agent.
Segment
Outline payer and channel segmentation and identify slow and more restrictive payers and PBMs across various channels.
Perform
Perform launch scenario analysis for appropriate analogs to identify what led to their respective uptake curves.
Complete
Complete the picture of how medical exceptions and market demand impact sales post-launch.
How We Help
Strategic Launch Report and Evaluate Forecast can help commercial teams produce more accurate forecasts of launch activity, even in new indications and those with a lot of pipeline and/or competitive activity and limited payer coverage.
Reveal
Highlight potential obstacles from new drug launch policies.
Correlate
Correlate analogs’ policy uptake with sales volumes to get a complete picture and set realistic launch expectations.
Identify
Identify scenarios when agents with more restrictive or slow policy uptake still experienced sales uptake or vice versa.
Understand
Through color commentary from Evaluate and MMIT syndicated reports, understand the reasoning behind what payer did vs. what physicians did.
Learn More About Strategic Launch Report
Download the brochure to learn how your team can predict payer and PBM uptake for your new brand with precision.
Keep Up-to-Date with Key Insights From MMIT
Strategic Launch Report With In-Depth Interviews
Learn how a pharma company leveraged MMIT’s Strategic Launch Report combined with In-Depth Interviews to get a unique view into the market access path for its therapy.
Mobilizing Data for Product Launch Success
Learn how one small biopharma company achieved 95% payer coverage for its rare disease therapy using MMIT’s strategic data solutions.
Predicting Payer Uptake with Precision
Learn when and how to select the right analogs to set the most accurate expectations and payer strategy at launch.
Solutions to Support Your Strategy
Message Monitor
Use Message Monitor to capture key payer and IDN decision-makers’ insights around brand perception so you can better position your product against the competition.
Analytics
As the leading platform for pharma market access teams, MMIT Analytics analyzes comprehensive formulary, policy and restriction information to evaluate patient access for your brands, competitors and analogs.
Searchlight
Searchlight delivers policy change alerts within 24-48 hours, as well as AI-powered policy summaries, clear visual comparisons, and user-level personalization to turn noisy policy updates into targeted, strategic insights.
FormTrak
FormTrak connects comprehensive formulary and medical policy information to promotional templates to give field teams insights and promotional assets related to your brand’s drug coverage.
Coverage Search
Access detailed drug formulary status and medical policies with Coverage Search for iPad, iPhone, and Android devices.
Payer Landscape
MMIT Landscape is an easy-to-navigate application that enables account managers to segment payers by market share, line of business, geographic reach and key relationship.